English
Back
Download
Log in to access Online Inquiry
Back to the Top
Weight-loss drugmakers report strong earnings: Boon or bane?
Views 125K Contents 247

something similar

there's $Pieris Pharmaceuticals (PIRS.US)$ already got net margin, also has patient for cancer. still undervalue, got payment from contract of 350 Mio. When market respond positively I think 1-2 dollar is achievable.
Yeah and remember, not only giving profit to shareholders but people around the world. Biotech, medical facilities, pharmacy could be the next boom.
As usual it's still risky play in initial page, but we have seen $Tempest Therapeutics (TPST.US)$ is rallying like a real mad bull.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
4
+0
2
Translate
Report
15K Views
Comment
Sign in to post a comment
Retailers. love biotech small-mid cap stocks w marvelous gain. don't follow. Free ebook:laacademic.com
254
Followers
157
Following
1643
Visitors
Follow
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.